Picture of Diamyd Medical AB logo

DMYD B Diamyd Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Diamyd Medical Says Co Had Positive Interim Analysis Results For Phase 3 Trial In Type 1 Diabetes

July 30 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL ANNOUNCES POSITIVE INTERIM ANALYSIS RESULTS
FOR
PHASE 3 TRIAL IN TYPE 1 DIABETES
    * DIAMYD MEDICAL AB  - INTERIM ANALYSIS RESULTED IN
FAVORABLE
RECOMMENDATION TO CONTINUE TRIAL WITHOUT ANY MODIFICATIONS.

Source text for Eikon:  ID:nWkr8y27Tw 
Further company coverage:  DMYDb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Diamyd Medical AB

See all news